Maneka Mirchandaney – Evercore ISI Group

Evercore ISI Group

An analyst at Evercore ISI Group with 11 tracked ratings across 10 distinct tickers has a 66.7% success rate on the captured sample, with a focus on bullish ratings in one sector and a hold rating in another.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

20 days ago

2026-05-15 00:00:00+00

Track record

Aggregated

67% success rate

Bullish: 0
Hold: 1
Bearish: 0

Aggregated

Not available

Bullish: 5
Hold: 0
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
CRNX	2026-05-15	buy	$88.00	Aggregated
VRDN	2026-05-15	buy	$26.00	Aggregated
VRDN	2026-04-02	buy	$32.00	Aggregated
INCY	2026-03-05	unknown	$110.00	Aggregated
CRNXCRINETICS PHARMACEUTICALS INC	2023-09-11	unknown	$48.00	Aggregated
INKT	2023-03-22	buy	$3.00	Aggregated
INKTMINK THERAPEUTICS INC	2023-03-22	unknown	$3.00	Aggregated
INCYINCYTE CORP.	2022-08-03	hold	$78.00	Aggregated
NEUP	2022-01-10	buy	$17.00	Aggregated
VRDNVIRIDIAN THERAPEUTICS INC	2021-10-12	unknown	$40.00	Aggregated
HOWLWEREWOLF THERAPEUTICS INC	2021-05-25	unknown	$23.00	Aggregated

Tickers covered(10)

Ticker	Ratings	Last rating	Sources
CRNX	1	2026-05-15	Aggregated
VRDN	2	2026-05-15	Aggregated
INCY	1	2026-03-05	Aggregated
CRNXCRINETICS PHARMACEUTICALS INC	1	2023-09-11	Aggregated
INKT	1	2023-03-22	Aggregated
INKTMINK THERAPEUTICS INC	1	2023-03-22	Aggregated
INCYINCYTE CORP.	1	2022-08-03	Aggregated
NEUP	1

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.